Invacare Profit Margin 2006-2018 | IVC

Current and historical gross margin, operating margin and net profit margin for Invacare (IVC) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Invacare net profit margin as of June 30, 2018 is -6.8%.
Invacare Annual Profit Margins
Invacare Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.468B $0.967B
Invacare Corporation is a leading manufacturer and distributor in its markets for medical equipment used in non-acute care settings. At its core, the company designs, manufactures and distributes medical devices that help people to move, breathe, rest and perform essential hygiene. The company provides clinically complex medical device solutions for congenital (e.g., cerebral palsy, muscular dystrophy, spina bifida), acquired (e.g., stroke, spinal cord injury, traumatic brain injury, post-acute recovery, pressure ulcers) and degenerative (e.g., ALS, multiple sclerosis, chronic obstructive pulmonary disease (COPD), elderly, bariatric) ailments. The company's products are important parts of care for people with a wide range of challenges, from those who are active and involved in work or school each day and may need additional mobility or respiratory support, to those who are cared for in residential care settings, at home and in rehabilitation centers.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $62.968B 22.54
McKesson (MCK) United States $25.317B 9.69
Align Technology (ALGN) United States $25.238B 67.29
AmerisourceBergen (ABC) United States $19.520B 14.19
Laboratory Of America Holdings (LH) United States $17.257B 15.87
Cardinal Health (CAH) United States $15.596B 10.84
Henry Schein (HSIC) United States $12.561B 21.42
Cooper (COO) United States $12.495B 22.50
West Pharmaceutical Services (WST) United States $8.382B 43.34
DENTSPLY SIRONA (XRAY) United States $8.000B 14.00
Merit Medical Systems (MMSI) United States $3.405B 44.75
Patterson (PDCO) United States $2.197B 15.44
CONMED (CNMD) United States $2.013B 34.10
STAAR Surgical (STAA) United States $1.834B 245.47
Atrion (ATRI) United States $1.258B 37.29
Antares Pharma (ATRS) United States $0.535B 0.00
Lifevantage (LFVN) United States $0.152B 21.58
Endologix (ELGX) United States $0.127B 0.00
Aceto (ACET) United States $0.065B 42.40
Pro-Dex (PDEX) United States $0.041B 25.73
Biolase (BIOL) United States $0.027B 0.00
Retractable Technologies (RVP) United States $0.022B 0.00
Milestone Scientific (MLSS) United States $0.020B 0.00